Ever Supreme Bio Technology Co., Ltd
6712
Rank in Stocks
#12677
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Share Price
$4.47
Last synced: 2026-11-10
Market Cap
$448.78M
Change (1 day)
-1.01%
Change (1 year)
-9.16%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Ever Supreme Bio Technology Co., Ltd (6712)
Category
Healthcare
EPS for Ever Supreme Bio Technology Co., Ltd (6712)
EPS as of June 2026 TTM: $0.16
According to Ever Supreme Bio Technology Co., Ltd's latest financial reports, its current EPS (TTM) is $0.16. At the end of 2025 the company had an EPS of $0.16, an increase over its 2024 EPS of $0.13.
EPS history for Ever Supreme Bio Technology Co., Ltd from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.16 | -2.38% |
| 2025 | $0.16 | 23.31% |
| 2024 | $0.13 | -41.18% |
| 2023 | $0.21 | 145.31% |
| 2022 | $0.09 | -51.17% |
| 2021 | $0.18 | -418.51% |
| 2020 | $-0.06 | 33.49% |
| 2019 | $-0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | 9,925.61% |
US
|
|
| $-7.07 | -4,626.25% |
US
|
|
| $-5.29 | -3,486.68% |
AU
|
|
| $12.88 | 8,145.90% |
BE
|
|
| $21.56 | 13,702.82% |
NL
|
Questions about Ever Supreme Bio Technology Co., Ltd's earnings per share (EPS)
What is Ever Supreme Bio Technology Co., Ltd's earnings per share (EPS)?
Ever Supreme Bio Technology Co., Ltd's earnings per share (EPS) over the last twelve months is $0.16, as of Jun 2026.
What was Ever Supreme Bio Technology Co., Ltd's earnings per share (EPS) in 2025?
In 2025, Ever Supreme Bio Technology Co., Ltd's earnings per share (EPS) was $0.16, 23.08% more than in 2024 ($0.13).
How has Ever Supreme Bio Technology Co., Ltd's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Ever Supreme Bio Technology Co., Ltd's earnings per share (EPS) was highest in 2023 ($0.21) and lowest in 2020 ($-0.06).
How does Ever Supreme Bio Technology Co., Ltd's earnings per share (EPS) compare with similar companies?
Ever Supreme Bio Technology Co., Ltd's earnings per share (EPS) ($0.16) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.